Novavax Stock (NASDAQ: NVAX) stock price, news, charts, stock research, profile.
Open | $12.52 |
Close | $12.91 |
Volume / Avg. | 8.93M / 7.10M |
Day Range | $12.34 - $13.36 |
52 Wk Range | 3.53 - 23.86 |
Market Cap | $2.07B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 24.63% |
Days to Cover | 6.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Novavax (NASDAQ:NVAX) through any online brokerage.
Other companies in Novavax’s space includes: Centessa Pharmaceuticals (NASDAQ:CNTA), Kiniksa Pharmaceuticals (NASDAQ:KNSA), Bicycle Therapeutics (NASDAQ:BCYC), Nurix Therapeutics (NASDAQ:NRIX) and BioCryst Pharma (NASDAQ:BCRX).
Novavax has a consensus price target of $51.00.
The stock price for Novavax (NASDAQ: NVAX) is $12.9278 last updated September 20, 2024 at 7:34 PM EDT.
There are no upcoming dividends for Novavax.
Novavax’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Novavax.
Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.